CD4 and tuberculosis: Pronounced differences in short-term mortality and underlying prevalence of disseminated tuberculosis between HIV-positive inpatients and outpatients also means that current WHO policy (specific recommendation against use for screening, with use of TB-LAM indicated only for diagnostic purposes in patients with tuberculosis symptoms and CD4 counts <100 cells per μL or signs of severe illness) should remain in use for outpatients.21